Stryker Corporation is set to acquire Inari Medical, Inc. for $4.9 billion, enhancing its portfolio in the minimally invasive vascular therapies market.
Overview of the Deal
Acquirer: Stryker Corporation
Target: Inari Medical, Inc
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Implied Equity Va
Similar Deals
Novartis AG → Avidity Biosciences, Inc.
2026
Laborie Medical Technologies Corp. → JADA System
2026
GEON Performance Solutions → Foster Corporation
2025
Matthews International Corporation → The Dodge Company, Inc.
2025
Stryker Corporation
invested in
Inari Medical, Inc
in 2025
in a Merger deal
Disclosed details
Transaction Size: $4,900M
Revenue: $575M
EBITDA: $-26M
Enterprise Value: $4,600M
Equity Value: $4,800M
Multiples
EV/EBITDA: -176.2x
EV/Revenue: 8.0x
P/Revenue: 8.4x